Insulin NovoNordisk NovoRapid, Injektionslösung

7680550450024 CH-55045 Injektionslösung

Associated product:

INSULINE NovoRapid flac 10 ml
Insulin NovoNordisk NovoRapid, Injektionslösung
Insulin NovoNordisk NovoRapid, Injektionslösung
1 / 2
google

Article details

Package size
10
Selling units
10
Measure
ml
Galenic form
Injektionslösung
Galenic group
Injektion/Infusion

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
15/02/2023
Patient information leaflet
Français
15/02/2023
Patient information leaflet
Italien
15/02/2023
Summary of Product Characteristics
Allemand
24/06/2021
Summary of Product Characteristics
Français
24/06/2021
Summary of Product Characteristics
Italien
24/06/2021

Detailed composition

Substance Quantity Type Category
(N/A)
100.0 U Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
- Substance Konservierungsstoff (Conservateur)
(N/A)
- Substance Konservierungsstoff (Conservateur)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
1.9 MG Substance HBESI

Reimbursement information

Public price
CHF 37.90
Specialties list
Yes
Generic
No
SL addition date: 01/01/2000

Authorization holder

Novo Nordisk Pharma AG

8302 Kloten

Authorization information

Swissmedic authorization number
55045
Drug name
Insulin NovoNordisk NovoRapid, Injektionslösung
Galenic form
LSIMD
ATC Code
A10AB05
Authorization status
Z
Dispensing category
B
First authorization
15/06/1999
Authorization expiration date
31/12/9999
IT Number
07.06.1.
Domain
Human medicine
Field of application
Diabetes mellitus

Package details

Description (FR)
INSULINE NovoRapid flac 10 ml
Description (DE)
INSULIN NovoRapid Durchstf 10 ml
Market launch
15/06/1999
Narcotic (BTM)
No